- Coordinates
- PDB Format
- Method
- ELECTRON MICROSCOPY
- Oligo State
- hetero-4-1-mer
- Ligands
- 1 x NAG- NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
- 5 x ATP: ADENOSINE-5'-TRIPHOSPHATE(Non-covalent)
- 1 x K: POTASSIUM ION(Non-covalent)
- 5 x POV: (2S)-3-(hexadecanoyloxy)-2-[(9Z)-octadec-9-enoyloxy]propyl 2-(trimethylammonio)ethyl phosphate(Non-covalent)
POV.4: 14 residues within 4Å:- Chain A: L.84, W.91, L.100, H.115, S.116, F.117, S.118
- Chain D: I.146
- Chain E: L.3, A.4, F.5, S.12, Y.15, M.108
4 PLIP interactions:2 interactions with chain E, 1 interactions with chain D, 1 interactions with chain A- Hydrogen bonds: E:F.5, E:Y.15, A:F.117
- Hydrophobic interactions: D:I.146
POV.6: 7 residues within 4Å:- Chain B: L.84, M.88, W.91, L.100, H.115, S.116, F.117
1 PLIP interactions:1 interactions with chain B- Hydrogen bonds: B:F.117
POV.9: 8 residues within 4Å:- Chain B: P.143
- Chain C: L.84, M.88, W.91, L.100, H.115, S.116, F.117
6 PLIP interactions:5 interactions with chain C, 1 interactions with chain B- Hydrophobic interactions: C:L.84, C:L.84, C:W.91, C:F.117, B:P.143
- Hydrogen bonds: C:F.117
POV.11: 8 residues within 4Å:- Chain C: I.146
- Chain D: L.84, W.91, L.100, H.115, S.116, F.117, S.118
2 PLIP interactions:2 interactions with chain D- Hydrophobic interactions: D:L.84
- Hydrogen bonds: D:F.117
POV.19: 10 residues within 4Å:- Chain E: H.67, F.68, P.69, G.70, H.71, N.72, I.76, P.220, K.227
- Ligands: P5S.18
8 PLIP interactions:8 interactions with chain E- Hydrophobic interactions: E:N.72, E:I.76, E:I.76
- Hydrogen bonds: E:F.68, E:G.70, E:H.71, E:N.72, E:N.72
- 2 x P5S: O-[(R)-{[(2R)-2,3-bis(octadecanoyloxy)propyl]oxy}(hydroxy)phosphoryl]-L-serine(Non-covalent)
P5S.7: 10 residues within 4Å:- Chain A: F.55, L.56, V.151, I.154
- Chain B: W.68, P.69, L.72, L.80
- Chain E: K.134, I.137
5 PLIP interactions:1 interactions with chain E, 3 interactions with chain A, 1 interactions with chain B- Hydrophobic interactions: E:I.137, A:V.151, A:I.154, B:L.80
- Hydrogen bonds: A:L.56
P5S.18: 20 residues within 4Å:- Chain E: I.76, F.79, I.80, F.83, V.84, L.174, L.224, K.227, G.228, R.298, L.301, F.305, L.364, L.368, T.371, F.372, A.375
- Ligands: PTY.15, POV.19, PTY.21
13 PLIP interactions:13 interactions with chain E- Hydrophobic interactions: E:I.76, E:F.79, E:I.80, E:V.84, E:L.174, E:K.227, E:F.305, E:L.364, E:L.368, E:F.372
- Salt bridges: E:K.227, E:K.227, E:R.298
- 6 x PTY: PHOSPHATIDYLETHANOLAMINE(Non-covalent)
PTY.12: 6 residues within 4Å:- Chain A: V.89, L.92, A.96, L.144
- Chain E: G.20, V.21
5 PLIP interactions:4 interactions with chain A, 1 interactions with chain E- Hydrophobic interactions: A:V.89, A:L.92, A:A.96, A:L.144
- Hydrogen bonds: E:V.21
PTY.15: 12 residues within 4Å:- Chain E: W.65, H.125, T.129, V.222, N.223, L.225, S.226, W.231, Y.1254
- Ligands: PTY.17, P5S.18, PTY.21
7 PLIP interactions:7 interactions with chain E- Hydrophobic interactions: E:L.225, E:W.231, E:W.231
- Hydrogen bonds: E:N.223, E:S.226
- Salt bridges: E:H.125, E:H.125
PTY.16: 9 residues within 4Å:- Chain E: I.89, I.93, L.94, H.326, N.354, Y.356, V.357, V.360, L.1272
6 PLIP interactions:6 interactions with chain E- Hydrophobic interactions: E:I.89, E:I.93, E:L.94, E:V.357
- Hydrogen bonds: E:H.326, E:N.354
PTY.17: 7 residues within 4Å:- Chain E: W.231, N.234, A.235, K.238, V.1174, Y.1254
- Ligands: PTY.15
3 PLIP interactions:3 interactions with chain E- Hydrophobic interactions: E:W.231, E:V.1174, E:Y.1254
PTY.20: 9 residues within 4Å:- Chain E: F.83, L.311, F.314, L.318, F.321, D.325, L.358, A.365, Y.454
5 PLIP interactions:5 interactions with chain E- Hydrophobic interactions: E:F.83, E:F.314, E:A.365
- Hydrogen bonds: E:D.325, E:Y.454
PTY.21: 14 residues within 4Å:- Chain E: F.44, L.47, F.79, L.82, I.118, T.119, V.121, V.122, H.125, N.126, T.129, L.225
- Ligands: PTY.15, P5S.18
12 PLIP interactions:12 interactions with chain E- Hydrophobic interactions: E:F.44, E:L.47, E:F.79, E:F.79, E:L.82, E:T.119, E:V.121, E:V.122, E:V.122
- Hydrogen bonds: E:T.129
- Salt bridges: E:H.125, E:H.125
- 1 x BJX: Repaglinide(Non-covalent)
BJX.13: 18 residues within 4Å:- Chain A: M.1, S.3, K.5, G.6
- Chain E: R.306, Y.377, I.381, W.430, L.434, N.437, T.588, L.592, S.595, V.596, N.1245, R.1246, W.1297, R.1300
15 PLIP interactions:13 interactions with chain E, 2 interactions with chain A- Hydrophobic interactions: E:Y.377, E:I.381, E:L.434, E:T.588, E:L.592, E:L.592, E:L.592, E:V.596, E:W.1297, E:W.1297, A:S.3, A:K.5
- Hydrogen bonds: E:N.1245
- Salt bridges: E:R.1246, E:R.1300
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Sung, M.W. et al., Ligand-mediated Structural Dynamics of a Mammalian Pancreatic K ATP Channel. J.Mol.Biol. (2022)
- Release Date
- 2022-08-31
- Peptides
- ATP-sensitive inward rectifier potassium channel 11: ABCD
ATP-binding cassette sub-family C member 8: E - SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
BC
CD
DE
E - Membrane
-
We predict this structure to be a membrane protein.
- Coordinates
- PDB Format
- Method
- ELECTRON MICROSCOPY
- Oligo State
- hetero-4-1-mer
- Ligands
- 1 x NAG- NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
- 5 x ATP: ADENOSINE-5'-TRIPHOSPHATE(Non-covalent)
- 1 x K: POTASSIUM ION(Non-covalent)
- 5 x POV: (2S)-3-(hexadecanoyloxy)-2-[(9Z)-octadec-9-enoyloxy]propyl 2-(trimethylammonio)ethyl phosphate(Non-covalent)
- 2 x P5S: O-[(R)-{[(2R)-2,3-bis(octadecanoyloxy)propyl]oxy}(hydroxy)phosphoryl]-L-serine(Non-covalent)
- 6 x PTY: PHOSPHATIDYLETHANOLAMINE(Non-covalent)
- 1 x BJX: Repaglinide(Non-covalent)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Sung, M.W. et al., Ligand-mediated Structural Dynamics of a Mammalian Pancreatic K ATP Channel. J.Mol.Biol. (2022)
- Release Date
- 2022-08-31
- Peptides
- ATP-sensitive inward rectifier potassium channel 11: ABCD
ATP-binding cassette sub-family C member 8: E - SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
BC
CD
DE
E - Membrane
-
We predict this structure to be a membrane protein.